Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA

Journal Title: NanoWorld Journal - Year 2015, Vol 1, Issue 2

Abstract

RNA interference and the therapeutic applications using small interfering RNA was discovered more than 10 years ago and currently is used in various applications including in therapeutic field. However the research in this field is still in its infancy. Many challenges like safe delivery of targeted siRNA to nucleus and cytosol of cancerous cells without compromising the activity of siRNA needs to be addressed. We have overcome this hurdle with the help of nanotechnology using PLGA hollow nanoparticles (PLGAHNPs) and suppressing the oncogene of MYC transcription factors by using anti myc-siRNAs in human cancer cell lines. siRNA was encapsulated in PLGAHNPs. These spherical PLGAHNPs of size 70 nm had high efficiency of gene release at pH 4.2 under in vitro conditions. Cell penetrating peptide (CPP)- Tat peptide (TAT) and peptide nucleic acidnucleolus localizing signal (PNA-NLS) was used for siRNA delivery without affecting the therapeutic activity of siRNA. The siRNA duplex was prepared using T7 polymerase and double stranded DNA through in vitro transcription. Incubation of the siRNA encapsulated PLGAHNPs functionalized with TAT and PNA-NLS (TAT-siRNA-PNA-PLGAHNPs-siRNA) with cancer cells resulted in reduced cell proliferation. A downregulation of gene expression by 90% was observed even with low concentration of siRNA. We found complete arrest of cell division which was mediated by downregulation of MYC expression.

Authors and Affiliations

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar

Keywords

Related Articles

Advances in Polymer/Graphene Nanocomposite for Biosensor Application

In this article, polymer/graphene nanocomposite has been focused with reference to their application in biosensor. In this regard, various type of biosensors-based on polymer/graphene nanocomposite has been explored. Maj...

In Vitro Anticancer Activity of Green Synthesis Ruthenium Nanoparticle from Dictyota dichotoma Marine Algae

Nanomedicine is the most revolutionized procedure to a greater extent in days to come. Among other nanoparticles Ruthenium compounds are well known for their high relevance as drug candidates, though they have very littl...

Langmuir-Blodgett Protein Multilayer Nanofilms by XFEL

Serial femtosecond crystallography (SFX) at X-ray free electron lasers (XFELs) has created many new opportunities for protein crystallography, including radiation damage mitigation and the study of dynamics at room tempe...

Ethanol Based Vesicular Carriers in Transdermal Drug Delivery: Nanoethosomes and Transethosomes in Focus

Transdermal route is one of the attractive routes for drug delivery due to its easy accessibility. Effective delivery of bioactive molecules through skin is however, still a challenge. The development of vesicular formul...

Proceedings of the First NanoWorld Conference in Boston (NWC-2016). Part III: Featured Presentations

The purpose of the current studies was to determine what role the microvessel endothelial cells in brain inflammation and neurotoxicity associated with colloidal metallic nanoparticles (NPs). A primary culture of rat bra...

Download PDF file
  • EP ID EP223085
  • DOI 10.17756/nwj.2015-005
  • Views 144
  • Downloads 0

How To Cite

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar (2015). Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA. NanoWorld Journal, 1(2), 32-45. https://europub.co.uk./articles/-A-223085